Clinical Trial Update: Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated intensive insulin glulisine therapy added to basal insulin and oral glucose-lowering drugs in adults with Type 2 diabetes inadequately…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED